NGEN
NervGen Pharma Corp.
1.90$
-0.5%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures per share in CAD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | |
| – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | |
| – | 0.03 | 0.26 | 0.19 | 0.18 | 0.31 | 0.13 | 0.23 | 0.19 | |
| – | – | – | – | – | 0.12 | 0.16 | 0.14 | 0.15 | |
| 0.00 | 0.05 | 0.39 | 0.35 | 0.33 | 0.43 | 0.30 | 0.37 | 0.35 | |
| 0.00 | -0.05 | -0.39 | -0.35 | -0.33 | -0.43 | -0.30 | -0.37 | -0.35 | |
| – | – | – | – | – | 0.01 | 0.00 | – | – | |
| 0.00 | -0.05 | -0.39 | -0.35 | -0.33 | -0.39 | -0.38 | -0.36 | -0.61 | |
| 0.00 | -0.05 | -0.39 | -0.35 | -0.33 | -0.39 | -0.38 | -0.36 | -0.61 | |
| 0.00 | -0.05 | -0.39 | -0.35 | -0.33 | -0.38 | -0.38 | -0.36 | -0.08 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.